Medicus Pharma’s (MDCX) Buy Rating Reiterated at D. Boral Capital
D. Boral Capital reaffirmed their buy rating on shares of Medicus Pharma (NASDAQ:MDCX – Free Report) in a research note published on Monday,Benzinga reports. D. Boral Capital currently has a $14.00 target price on the stock. Other equities research analysts have also recently issued reports about the stock. Brookline Capital Management upgraded shares of Medicus […]
D. Boral Capital reaffirmed their buy rating on shares of Medicus Pharma (NASDAQ:MDCX – Free Report) in a research note published on Monday,Benzinga reports. D. Boral Capital currently has a $14.00 target price on the stock. Other equities research analysts have also recently issued reports about the stock. Brookline Capital Management upgraded shares of Medicus […]
